dc.contributor.author
Saleh, Ayatallah
dc.contributor.author
Schulz, Josefine
dc.contributor.author
Schlender, Jan-Frederik
dc.contributor.author
Aulin, Linda B. S.
dc.contributor.author
Konrad, Amrei-Pauline
dc.contributor.author
Kluwe, Franziska
dc.contributor.author
Mikus, Gerd
dc.contributor.author
Huisinga, Wilhelm
dc.contributor.author
Kloft, Charlotte
dc.contributor.author
Michelet, Robin
dc.date.accessioned
2025-09-25T11:40:04Z
dc.date.available
2025-09-25T11:40:04Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/48626
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48350
dc.format.extent
3 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
Voriconazole Metabolism
en
dc.subject
Clinical Insights
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik
dc.title
Author’s Reply to Helsby and Hannam: ‘Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights’
dc.type
Letter to the Editor
dcterms.bibliographicCitation.doi
10.1007/s40262-025-01553-w
dcterms.bibliographicCitation.journaltitle
Clinical Pharmacokinetics
dcterms.bibliographicCitation.number
9
dcterms.bibliographicCitation.pagestart
1429
dcterms.bibliographicCitation.pageend
1431
dcterms.bibliographicCitation.volume
64
dcterms.bibliographicCitation.url
https://doi.org/10.1007/s40262-025-01553-w
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie
refubium.funding
Springer Nature DEAL
refubium.note.author
Gefördert aus Open-Access-Mitteln der Freien Universität Berlin.
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1179-1926
